8[1]NINDS t-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med, 1995, 333: 1581-1587.
9[2]Marler J, Tilley BC, Mci L, et al. Earlier treatment associated with better outcome in the NINDS t-PA trial. Stroke, 1999, 30: 244.
10[3]NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke: subgroup analysis of the NINDS t-PA Stroke Trial.Stroke, 1997, 28: 2119-2125.
9G. Ladurner,P. Kalvach,H. Moessler. Neuroprotective treatment with Cerebrolysin in patients with acute stroke: a randomised controlled trial[J] 2005,Journal of Neural Transmission(3):415~428